Detalles de la búsqueda
1.
CaboCombo: a prospective, phase IV study of first-line cabozantinib + nivolumab for advanced renal cell carcinoma.
Future Oncol
; 20(13): 811-819, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403652
2.
Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence.
Clin Genitourin Cancer
; 22(1): 84-97, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101983
3.
Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulationâ©.
Horm Res Paediatr
; 87(4): 224-232, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28334719
4.
Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer.
Adv Ther
; 34(2): 513-523, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028737
5.
Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer.
Ther Adv Urol
; 7(3): 125-34, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26161143
6.
Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Horm Res Paediatr
; 83(4): 268-79, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25765099
7.
Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study.
J Clin Endocrinol Metab
; 98(6): E1122-30, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23596138
Resultados
1 -
7
de 7
1
Próxima >
>>